These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22122518)

  • 21. Small-molecule xenomycins inhibit all stages of the Plasmodium life cycle.
    Erath J; Gallego-Delgado J; Xu W; Andriani G; Tanghe S; Gurova KV; Gudkov A; Purmal A; Rydkina E; Rodriguez A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1427-34. PubMed ID: 25512429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triterpenoids as inhibitors of erythrocytic and liver stages of Plasmodium infections.
    Ramalhete C; da Cruz FP; Lopes D; Mulhovo S; Rosário VE; Prudêncio M; Ferreira MJ
    Bioorg Med Chem; 2011 Dec; 19(24):7474-81. PubMed ID: 22071523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. That was then but this is now: malaria research in the time of an eradication agenda.
    Kappe SH; Vaughan AM; Boddey JA; Cowman AF
    Science; 2010 May; 328(5980):862-6. PubMed ID: 20466924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-Activity Relationship Studies and Plasmodium Life Cycle Profiling Identifies Pan-Active N-Aryl-3-trifluoromethyl Pyrido[1,2- a]benzimidazoles Which Are Efficacious in an in Vivo Mouse Model of Malaria.
    Mayoka G; Njoroge M; Okombo J; Gibhard L; Sanches-Vaz M; Fontinha D; Birkholtz LM; Reader J; van der Watt M; Coetzer TL; Lauterbach S; Churchyard A; Bezuidenhout B; Egan TJ; Yeates C; Wittlin S; Prudêncio M; Chibale K
    J Med Chem; 2019 Jan; 62(2):1022-1035. PubMed ID: 30562027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biology and immunology of sporozoite invasion of liver cells and exoerythrocytic development of malaria parasites.
    Hollingdale MR
    Prog Allergy; 1988; 41():15-48. PubMed ID: 3043420
    [No Abstract]   [Full Text] [Related]  

  • 26. A clash to conquer: the malaria parasite liver infection.
    Mikolajczak SA; Kappe SH
    Mol Microbiol; 2006 Dec; 62(6):1499-506. PubMed ID: 17074071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug resistance of Plasmodium and rational application of antimalarials].
    Liu DQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Oct; 23(5 Suppl):355-61. PubMed ID: 16562468
    [No Abstract]   [Full Text] [Related]  

  • 28. 2-Acylamino-5-chlorobenzophenones with enhanced selectivity towards malaria parasites.
    Heinrich S; Altenkämper M; Bechem B; Perruchon J; Ortmann R; Dahse HM; Wang Y; Lanzer M; Schlitzer M
    Eur J Med Chem; 2011 Apr; 46(4):1331-42. PubMed ID: 21345543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro models for human malaria: targeting the liver stage.
    Valenciano AL; Gomez-Lorenzo MG; Vega-Rodríguez J; Adams JH; Roth A
    Trends Parasitol; 2022 Sep; 38(9):758-774. PubMed ID: 35780012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomadic or sessile: can Kupffer cells function as portals for malaria sporozoites to the liver?
    Frevert U; Usynin I; Baer K; Klotz C
    Cell Microbiol; 2006 Oct; 8(10):1537-46. PubMed ID: 16911567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New hope in the fight against malaria?
    Rodrigues T; Moreira R; Lopes F
    Future Med Chem; 2011 Jan; 3(1):1-3. PubMed ID: 21428820
    [No Abstract]   [Full Text] [Related]  

  • 32. Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites.
    Glenn MP; Chang SY; Hucke O; Verlinde CL; Rivas K; Hornéy C; Yokoyama K; Buckner FS; Pendyala PR; Chakrabarti D; Gelb M; Van Voorhis WC; Sebti SM; Hamilton AD
    Angew Chem Int Ed Engl; 2005 Aug; 44(31):4903-6. PubMed ID: 16007716
    [No Abstract]   [Full Text] [Related]  

  • 33. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational approach to the treatment of malaria.
    Valecha N; Srivastava A; Sharma VP
    Natl Med J India; 1994; 7(6):281-7. PubMed ID: 7841881
    [No Abstract]   [Full Text] [Related]  

  • 35. [The pharmacology of antimalarials].
    Fernex M; Leimer R
    Schweiz Rundsch Med Prax; 1986 Apr; 75(16):438-45. PubMed ID: 3518010
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug resistance in malaria.
    Parija SC; Praharaj I
    Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Overview of Currently Available Antimalarials.
    Gorobets NY; Sedash YV; Singh BK; Poonam ; Rathi B
    Curr Top Med Chem; 2017; 17(19):2143-2157. PubMed ID: 28137228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protozoa (plasmodium) : mechanisms of resistance to antimalarials].
    Iwagami M; Kano S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():497-501. PubMed ID: 17455670
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug resistant malaria].
    Kano S
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():214-20. PubMed ID: 12717974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.